Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response

Journal of Virology

Volumn 74, Issue 17, 2000, Pages 7895-7902

  Flanagan, E B ^a   Ball, L A ^a   Wertz, G W ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; NUCLEOCAPSID PROTEIN; THROMBOSPONDIN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GENE ORDER; GENE REARRANGEMENT; GENE TRANSLOCATION; IMMUNE RESPONSE; IMMUNOGENICITY; LETHALITY; MALE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RHABDOVIRUS; TRANSCRIPTION REGULATION; VACCINE PRODUCTION; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; ANTIBODY FORMATION; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; GENE EXPRESSION REGULATION, VIRAL; GENE REARRANGEMENT; MALE; MEMBRANE GLYCOPROTEINS; MICE; PROMOTER REGIONS (GENETICS); RHABDOVIRIDAE INFECTIONS; VERO CELLS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033897397     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.17.7895-7902.2000     Document Type: Article

References (46)

1. Sequential transcription of the genes of vesicular stomatitis virus
2. Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis
3. Order of transcription of genes of vesicular stomatitis virus
4. Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus
5. Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription
6. Review of the 1995 vesicular stomatitis outbreak in the western United States
7. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus
8. Genetic manipulation of non-segmented negative-strand RNA viruses
9. Nonsegmented negative-strand RNA viruses: Genetics and manipulation of viral genomes
10. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero)
11. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
12. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus
13. Financial impact of the 1995 outbreak of vesicular stomatitis on 16 beef ranches in Colorado
14. Vesicular stomatitis virus RNA replication: A role for the NS protein
15. Localization attenuation and discontinuous synthesis during vesicular stomatitis virus transcription
16. Recombinant vesicular stomatitis virus expressing the respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion
17. The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody
18. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses
19. Fewer protective cytotoxic T-cell epitopes than T-helper cell epitopes on vesicular stomatitis virus
20. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: Distinct mechanisms of action in vivo
21. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies
22. Vaccinia virus recombinants: Expression of VSV genes and protective immunization of mice and cattle
23. Phenotypic variation in the interferon-inducing capacity of vesicular stomatitis virus with rearranged genomes
24. Neuropathological and immunofluorescence studies of experimental vesicular stomatitis encephalitis in mice
25. Applications of poxvirus vectors to vaccination: An update
26. Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs
27. N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus
28. Kinetic, quantitative, and functional analysis of multiple forms of the vesicular stomatitis virus nucleocapsid protein in infected cells
29. Viral proteins required for the in vitro replication of vesicular stomatitis virus defective interfering particle genome RNA
30. The genetics of paramyxoviruses
31. Monopartite negative strand RNA genomes
32. Enhanced mutability associated with a temperature-sensitive mutant of vesicular stomatitis virus
33. A simple method of estimating fifty percent endpoints
34. Attenuated vesicular stomatitis viruses as vaccine vectors
35. Mapping of the dominant neutralizing antigenic sites of a virus using infected cells
36. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity
37. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus
38. Influence of host factors on neuroinvasiveness of vesicular stomatitis virus
39. Foreign glycoproteins expressed from recombinant vesicular stomatitis virus are incorporated efficiently into virus particles
40. 1997 vesicular stomatitis virus (VSV) outbreak in the United States
41. Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells
42. Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular stomatitis virus
43. Epizootic vesicular stomatitis in Colorado, 1982: Epidemiological studies along the northern Colorado front range
44. Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus
45. Recovery of infectious vesicular stomatitis virus entirely from cDNA clones